Form 4 for INTT INTEST CORP
Accepted 2025-03-19 00:00:00 ET · period of report 2025-03-17 · accession 0001062993-25-005902 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-19 | 2025-03-17 | INTT | Grant Richard N. Jr. | Pres, CEO, Dir | A - Grant | $0.00 | +51.7K | 212.7K | +32% | $0 |
| DM | 2025-03-19 | 2025-03-17 | INTT | Grant Richard N. Jr. | Pres, CEO, Dir | A - Grant | $0.2347 | +45.7K | 2,327 | New | +$10.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | A | A | 25,840 | $0.00 | 186,897 | D | — | — | (F1) These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026. |
| 2 | Common | Common Stock | 2025-03-17 | A | A | 25,840 | $0.00 | 212,737 | D | — | — | (F2) These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 17, 2028 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 38,760. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-03-17 | A | A | 43,384 | $0.00 | 43,384 | D | $7.74 · — to 2035-03-16 | 43,384 Common Stock | (F4) This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-03-17 | A | A | 2,327 | $4.61 | 2,327 | D | $7.74 · — to 2035-03-16 | 2,327 Common Stock | (F3) This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $10,723. This option will vest in four equal annual installments commencing on March 17, 2026. |